Point72 Asia (Singapore) Pte. Ltd. Amicus Therapeutics, Inc. Transaction History
Point72 Asia (Singapore) Pte. Ltd.
- $381 Billion
- Q1 2025
A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 11,418 shares of FOLD stock, worth $67,937. This represents 0.02% of its overall portfolio holdings.
Number of Shares
11,418Holding current value
$67,937% of portfolio
0.02%Shares
3 transactions
Others Institutions Holding FOLD
# of Institutions
315Shares Held
319MCall Options Held
378KPut Options Held
575K-
Wellington Management Group LLP Boston, MA29.2MShares$174 Million0.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA29.1MShares$173 Million0.0% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$145 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY21.5MShares$128 Million7.33% of portfolio
-
Avoro Capital Advisors LLC New York, NY20.5MShares$122 Million2.71% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $1.67B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...